Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

NASDAQ Welcomes Cellular Dynamics International, Inc. to The NASDAQ Stock Market

NDAQ
NASDAQ Welcomes Cellular Dynamics International, Inc. to The NASDAQ Stock Market

NEW YORK, July 25, 2013 (GLOBE NEWSWIRE) -- The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) announced that trading of Cellular Dynamics International, Inc. (Nasdaq:ICEL), a developer and manufacturer of fully functioning human cells in industrial quantities to precise specifications, commenced on The NASDAQ Stock Market on July 25, 2013.

Cellular Dynamics International, Inc. "CDI" develops and manufactures fully functioning human cells in industrial quantities to precise specifications. CDI is a leading developer of stem cell technologies for in vitro use in drug discovery, toxicity testing and chemical safety; in vivo and cell-based therapeutic research; and stem cell banking. CDI harnesses its unique manufacturing technology to produce differentiated tissue cells in industrial quality, quantity and purity from any individual's stem cell line created from a standard blood draw. CDI was founded in 2004 by Dr. James Thomson, a pioneer in human pluripotent stem cell research at the University of Wisconsin-Madison. CDI's headquarters are located in Madison, Wisconsin, with a second facility in Novato, California.

"CDI is at the forefront of stem cell technologies and research," said Nelson Griggs, Senior Vice President, NASDAQ OMX Corporate Client Group. "NASDAQ OMX is excited to welcome CDI to The NASDAQ Stock Market and looks forward to watching CDI grow as a public company."

NASDAQ OMX has consistently been the exchange of choice for groundbreaking biotechnology companies, including CDI, Amgen Inc. and Celgene Corp.

About NASDAQ OMX Group:

The inventor of the electronic exchange, The NASDAQ OMX Group, Inc., fuels economies and provides transformative technologies for the entire lifecycle of a trade - from risk management to trade to surveillance to clearing. In the U.S. and Europe, we own and operate 26 markets, 3 clearinghouses and 5 central securities depositories supporting equities, options, fixed income, derivatives, commodities, futures and structured products. Able to process more than 1 million messages per second at sub-40 microsecond speeds with 99.99% uptime, our technology drives more than 70 marketplaces in 50 developed and emerging countries into the future, powering 1 in 10 of the world's securities transactions. Our award-winning data products and worldwide indexes are the benchmarks in the financial industry. Home to approximately 3,400 listed companies worth $6 trillion in market cap whose innovations shape our world, we give the ideas of tomorrow access to capital today. Welcome to where the world takes a big leap forward, daily. Welcome to the NASDAQ OMX Century. To learn more, visit nasdaqomx.com. Follow us on Facebook (http://www.facebook.com/NASDAQ) and Twitter (http://www.twitter.com/nasdaqomx). (Symbol: NDAQ and member of S&P 500)

The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular security or an overall investment strategy. Neither The NASDAQ OMX Group, Inc. nor any of its affiliates makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Statements regarding NASDAQ-listed companies are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.

-NDAQG-

CONTACT: NASDAQ OMX Media Contact:
         Joe Christinat
         (646) 441-5121
         joseph.christinat@nasdaqomx.com

company logo



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today